“Efficacy and Safety of Tyrosine Kinase 2 Inhibitor Deucravacitinib in Psoriasis : A Systematic Review and Drug-Response Meta Analysis of RCTs”. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia (December 10, 2025): 10. Accessed July 25, 2026. https://jimki.bapin.or.id/main/article/view/961.